(Reuters) – OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.
OxyContin maker stops promoting opioids, cuts sales staff
